Aspirin Prevents and Partially Reverses Adrenocorticotropic Hormone-Induced Hypertension in the Rat

American Journal of Hypertension

Volumn 20, Issue 11, 2007, Pages 1222-1228

  Zhang, Yi ^a   Miao, Yuchun ^a   Whitworth, Judith A ^a  

^a Biology and Environment   (Australia)

Author keywords

Aspirin; glucocorticoid; hypertension; superoxide

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; LUCIGENIN; SODIUM CHLORIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG POTENCY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; THYMUS; TREATMENT RESPONSE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOOD PRESSURE; BODY WEIGHT; DEXAMETHASONE; ENZYME INHIBITORS; HYPERTENSION; MALE; NADPH OXIDASE; ORGAN SIZE; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; THYMUS GLAND;

EID: 35348882580     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.07.009     Document Type: Article

References (33)

1. Lou Y.K., Wen C., Li M., Adams D.J., Wang M.X., Yang F., Morris B.J., and Whitworth J.A. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension 37 (2001) 1164-1170
2. Turner S.W., Wen C., Li M., and Whitworth J.A. L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 27 (1996) 184-189
3. Wen C., Li M., and Whitworth J.A. Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine. Clin Exp Pharmacol Physiol 27 (2000) 887-890
4. Wen C., Li M., Fraser T., Wang J., Turner S.W., and Whitworth J.A. L-Arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Press 9 (2000) 298-304
5. Zhang Y., Jang R., Mori T.A., Croft K.D., Schyvens C.G., McKenzie K.U., and Whitworth J.A. The anti-oxidant tempol reverses and partially prevents adrenocorticotropic hormone-induced hypertension in the rat. J Hypertens 21 (2003) 1513-1518
6. Zhang Y., Croft K.D., Mori T.A., Schyvens C.G., McKenzie K.U.S., and Whitworth J.A. The anti-oxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 17 (2004) 260-265
7. Zhang Y., Chan M.M., Andrews M.C., Mori T.A., Croft K.D., McKenzie K.U., Schyvens C.G., and Whitworth J.A. Apocynin but not allopurinol prevents and reverses ACTH-induced hypertension in the rat. Am J Hypertens 18 (2005) 910-916
8. Mondo C.K., Zhang Y., de Macedo Possamai V., Miao Y., Schyvens C.G., McKenzie K.U., Hu L., Guo Z., and Whitworth J.A. N-Acetylcysteine partially prevents but does not reverse ACTH-induced hypertension in the rat. Clin Exp Hypertens 28 (2006) 73-84
9. Wen C., Fraser T., Li M., Turner S.W., and Whitworth J.A. Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat. J Hypertens 17 (1999) 1715-1723
10. Hu L., Zhang Y., Lim P.S., Miao Y., Tan C., McKenzie K.U., Schyvens C.G., and Whitworth J.A. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 19 (2006) 413-418
11. Mehta J.L. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects. Clin Cardiol 21 (1998) 879-884
12. Metz S.A. Anti-inflammatory agents as inhibitors of prostaglandin synthesis in man. Med Clin North Am 65 (1981) 713-757
13. El Midaoui A., Wu R., and de Champlain J. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J Hypertens 20 (2002) 1407-1412
14. Wu R., Lamontagne D., and de Champlain J. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 105 (2002) 387-392
15. Wu R., Laplante M.A., and de Champlain J. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens 22 (2004) 793-801
16. Fraser T.B., Turner S.W., Mangos G.J., Ludbrook J., and Whitworth J.A. Comparison of telemetric and tail-cuff blood pressure monitoring in adrenocorticotrophic hormone-treated rats. Clin Exp Pharmacol Physiol 28 (2001) 831-835
17. Lip G.Y. Antithrombotic therapy: standard therapy in essential hypertension?. Prog Cardiovasc Dis 49 (2006) 11-15
18. Dubey K., Balani D.K., and Pillai K.K. Potential adverse interaction between aspirin and lisinopril in hypertensive rats. Hum Exp Toxicol 22 (2003) 143-147
19. Dusting G.J., Drysdale T., Veroni M., and Doyle A.E. Differences in arachidonic acid metabolism and effects of aspirin between one- and two-kidney Goldblatt hypertensive rats. Clin Exp Pharmacol Physiol 10 (1983) 355-360
20. Schirner M., and Taube C. Different effects of aspirin on blood pressure of spontaneously hypertensive rats (SHR) with high and spontaneously low levels of blood pressure. Br J Pharmacol 109 (1993) 900-901
21. Tauseef M., Sharma K.K., and Fahim M. Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. Eur J Pharmacol 556 (2007) 136-143
22. Podhaisky H.P., Abate A., Polte T., Oberle S., and Schroder H. Aspirin protects endothelial cells from oxidative stress-possible synergism with vitamin E. FEBS Lett 417 (1997) 349-351
23. Miao Y., Zhang Y., Lim P.S., Kanjanapan Y., Mori T.A., Croft K.D., Earl J., Lee Y., McKenzie K.U.S., Hu L., and Whitworth J.A. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat. Am J Hypertens 20 (2007) 304-310
24. Whitworth J.A., Schyvens C.G., Zhang Y., Andrews M.C., Mangos G.J., and Kelly J.J. The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 20 (2002) 1035-1043
25. Radomski M., Palmer R., and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci (USA) 87 (1990) 10043-10047
26. Zhang Y., Schyvens C.G., McKenzie K.U.S., Morris B.J., and Whitworth J.A. Lipopolysaccharide reverses adrenocorticotrophic hormone-induced hypertension in the rat. Hypertens Res 26 (2003) 427-432
27. Andrews M.C., Schyvens C.G., McKenzie K.U.S., Zhang Y., and Whitworth J.A. Nitric oxide donation partially reverses adrenocorticotrophic hormone-induced hypertension in rats. Clin Exp Hypertens 26 (2004) 499-509
28. Schyvens C.G., Cowden W.B., Zhang Y., McKenzie K.U.S., and Whitworth J.A. Hemodynamic effects of the nitric oxide donor DETA/NO in mice. Clin Exp Hypertens 26 (2004) 525-535
29. Wallerath T., Godecke A., Molojavyi A., Li H., Schrader J., and Forstermann U. Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene. Nitric Oxide 10 (2004) 36-41
30. Kelly J.J., Tam S.H., Williamson P.M., Lawson J., and Whitworth J.A. Nitric oxide system and cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol 25 (1998) 945-946
31. Taubert D., Berkels R., Grosser N., Schroder H., Grundemann D., and Schomig E. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol 143 (2004) 159-165
32. Grosser N., and Schroder H. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb Vasc Biol 23 (2003) 1345-1351
33. Li M., Wen C., Martin A., and Whitworth J.A. Dehydroepiandrosterone does not prevent adrenocorticotrophin-induced hypertension in conscious rats. Clin Exp Pharmacol Physiol 23 (1996) 435-437